Gentilella, R., Romera, I., Nicolay, C., Buzzetti, R., Vázquez, L. A., & Sesti, G. (2019). Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents. Diabetes Ther.
Παραπομπή Chicago StyleGentilella, Raffaella, Irene Romera, Claudia Nicolay, Raffaella Buzzetti, Luis Alberto Vázquez, και Giorgio Sesti. "Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents." Diabetes Ther 2019.
Παραπομπή MLAGentilella, Raffaella, et al. "Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents." Diabetes Ther 2019.